Dec. 5 at 3:09 PM
TD Cowen⬆️the PT on
$VERA to
$73 from
$60 and reiterated at a Buy rating.
$TVTX $OTSKY $JBIO $VRTX ABBV ALNY IONS
Here's what TD Cowen had to say:
We are increasing our estimated gross annual pricing for ataci' in IgAN to
$350K based on new comparator product pricing, increasing our PT to
$73 based on higher peak US sales of
$1.64B in 2033.
Mgmt said Ph2 ataci' PIONEER IgAN/pMN/FSGS-data may come in 1Q26. VERA may pursue a monthly sNDA path as the formulation is the same as weekly. A June/July PDUFA is likely for weekly dosing in IgAN.
